Ben Richardson, CEO at SulNOx, confident they can cost-effectively decarbonise commercial shipping. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksARDN.L Regulatory News (ARDN)

  • There is currently no data for ARDN

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Statement Regarding Share Price Movement

19 Mar 2020 07:00

RNS Number : 7092G
Arden Partners plc
19 March 2020
 

Arden Partners plc

("Arden" or the "Company")

 

Statement Regarding Share Price Movement

Arden (AIM: ARDN) has noted the recent downward movement in its share price, in particular on 18 March 2020, on very small volumes.

The Board understands the current volatile nature of the stock market and the impact of this on relatively illiquid stocks, but it wishes to advise shareholders that, as at 29 February 2020, the unaudited net asset value of the Company was £5.6m (equating to a net asset value per share of 19.2 pence).

The Company's preliminary results statement (released on 3 February 2020), highlighted that it was well capitalised as at its latest year end and the Board confirms that it remains so.

The Board's priority will be to protect the Company's balance sheet whilst remaining focussed on delivering its stated growth strategy and on servicing Arden's clients' needs. This remains the case despite the current difficult market conditions.

For further enquiries:

Arden Partners plc

020 7614 5900

Steve Douglas - Group Finance Director

 

GCA Altium Limited

 

020 7484 4040

Sam Fuller / Tim Richardson

 

Notes for editors

Arden is a dedicated corporate adviser and multi-service stockbroker to small and mid-cap companies in the UK and their investors.

The absolute core of our business is the effective management of the needs of our significant and growing base of corporate clients, and the effective support of their relationships with existing and potential shareholders. 

These relationships are enhanced by the quality of our corporate finance advice and industry research, and the strong market presence of our sales and trading teams.

Our corporate finance capabilities encompass M&A, corporate finance advisory, broking and Sponsor and NOMAD services. We represent our clients in private transactions and AIM and Main Market share issues.

Our research is designed to be sector focused, concentrating on top down thematic trends which highlight companies giving investors an exposure to the real growth areas of the small-cap and AIM markets.

It is the job of the sales team to keep institutions abreast of these themes and stock ideas. When there is a requirement for our corporate clients to raise money to fulfil their growth ambitions, the sales team is in a strong position to effect this, with its entrenched relationships with the UK institutional and non-institutional markets.

Our market making and trading teams provide liquidity in the shares of our corporate clients. We also trade the shares of non-client corporates on behalf of institutions.

The recently added Arden Wealth Management team offers a bespoke discretionary service to our clients, with the ability to trade/invest in equities, bonds and a range of global investment funds.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
SPMEANDPFALEEFA
Date   Source Headline
10th Mar 20143:58 pmRNSDirector/PDMR Shareholding
26th Feb 201410:30 amRNSHolding(s) in Company
26th Feb 201410:24 amRNSHolding(s) in Company
19th Feb 20149:47 amRNSDirector/PDMR Shareholding
18th Feb 201410:19 amRNSDirector/PDMR Shareholding
12th Feb 201411:05 amRNSBlocklisting Six Monthly Return
17th Jan 20141:38 pmRNSHolding(s) in Company
17th Jan 201412:53 pmRNSHolding(s) in Company
16th Jan 20142:34 pmRNSHolding(s) in Company
14th Jan 20142:57 pmRNSAnnual Report and Accounts
14th Jan 20147:00 amRNSPreliminary Results - Year Ended 31 October 2013
22nd Nov 201310:40 amRNSBlocklisting Six Monthly Return
1st Nov 201311:46 amRNSHolding(s) in Company
1st Nov 201311:42 amRNSHolding(s) in Company
1st Nov 201311:42 amRNSHolding(s) in Company
1st Nov 20137:00 amRNSDirector/PDMR Shareholding
1st Nov 20137:00 amRNSTransaction in Own Shares and Total Voting Rights
12th Aug 20139:49 amRNSBlocklisting Six Monthly Return
1st Aug 20131:17 pmRNSHolding(s) in Company
1st Aug 201312:02 pmRNSHolding(s) in Company
1st Aug 201311:06 amRNSTotal Voting Rights
29th Jul 20131:00 pmRNSHolding(s) in Company
29th Jul 201312:59 pmRNSHolding(s) in Company
29th Jul 201312:54 pmRNSGrant of Options
26th Jul 20137:00 amRNSDirector's Dealing and Total Voting Rights
23rd Jul 20137:00 amRNSInterim Results - Six Months Ended 30 April 2013
18th Jul 201311:55 amRNSForm 8.5 (EPT/NON-RI)
31st May 20134:34 pmRNSTotal Voting Rights
22nd May 201310:49 amRNSBlocklisting Six Monthly Return
13th May 20133:36 pmRNSDirector's Dealing
8th May 201311:33 amRNSHolding(s) in Company
8th May 201311:32 amRNSHolding(s) in Company
8th May 201311:28 amRNSExercise of Options and Director's Holding
7th May 20135:41 pmRNSHolding(s) in Company
7th May 20133:55 pmRNSExercise of Options and Director's Holding
2nd May 20133:12 pmRNSHolding(s) in Company
2nd May 20133:12 pmRNSHolding(s) in Company
1st May 20139:13 amRNSTransaction in Own Shares and Total Voting Rights
1st May 20137:00 amRNSDirectors' Dealings and Total Voting Rights
26th Apr 20131:02 pmRNSHolding(s) in Company
26th Apr 20131:00 pmRNSHolding(s) in Company
26th Apr 20137:00 amRNSDirector's Dealing
16th Apr 20132:11 pmRNSCancellation of Treasury Shares
14th Mar 201312:17 pmRNSResult of AGM
14th Mar 201311:00 amRNSAGM Statement
12th Feb 201310:38 amRNSBlocklisting Interim Review
8th Feb 201311:57 amRNSAnnual Report and Accounts
4th Feb 20133:10 pmRNSHolding(s) in Company
31st Jan 20139:49 amRNSDirector's Dealing
30th Jan 20134:09 pmRNSShare purchase by EBT

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.